The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of dual immune checkpoint blockade (ICB) plus androgen receptor (AR) blockade to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC).
 
David B. Page
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; NanoString Technologies; NanoString Technologies; Nektar; Puma Biotechnology; Puma Biotechnology; Syndax
Speakers' Bureau - Genentech/Roche
Research Funding - Bristol-Myers Squibb; MedImmune (Inst); Merck
Expert Testimony - Philips Healthcare
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune
 
Isaac K Kim
No Relationships to Disclose
 
Brie Chun
No Relationships to Disclose
 
William L Redmond
Research Funding - Aeglea Biotherapeutics; Bristol-Myers Squibb; Galectin Therapeutics; MedImmune; Merck; Nektar; Tesaro; Ventana Medical Systems
 
Maritza Martel
No Relationships to Disclose
 
Motomi Mori
No Relationships to Disclose
 
Dottie Wadell
No Relationships to Disclose
 
Nicole Moxon
No Relationships to Disclose
 
Staci L. Mellinger
No Relationships to Disclose
 
Walter John Urba
Leadership - Leidos Biomedical Research
Stock and Other Ownership Interests - Pfizer
Honoraria - Bristol-Myers Squibb; Celldex; MedImmune; Newlink Genetics; OncoSec
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celldex; eTheRNA; GreenPeptide; MedImmune (Inst); Newlink Genetics; OncoSec
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - AgonOx; Bristol-Myers Squibb; eTheRNA; Leidos Biomedical Research; MedImmune
 
Ayca Gucalp
Consulting or Advisory Role - Innocrin Pharma; Pfizer
Research Funding - Innocrin Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Innocrin Pharma
 
Tiffany A. Traina
Consulting or Advisory Role - Aduro Biotech; Advaxis; Astellas Pharma; AstraZeneca; Athenex; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Halozyme; Halozyme; Halozyme; Halozyme; Halozyme; Innocrin Pharma; Medivation; Merck; Pfizer; Puma Biotechnology; Samsung
Speakers' Bureau - Roche/Genentech
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Pfizer (Inst)